Role of mucosal immunity in preventing genital herpes infection.
about
The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota.Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture.Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:CDiagnosing of herpes simplex virus infections in suspected patients using real-time PCRA genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challengeCXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous systemMucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract.Stone age diseases and modern AIDS.Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells.Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanismHerpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice.Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes.Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) InfectionLeft out but not forgotten: Should closer attention be paid to coinfection with herpes simplex virus type 1 and HIV?Coculturing human endometrial epithelial cells and stromal fibroblasts alters cell-specific gene expression and cytokine production.New concepts in herpes simplex virus vaccine development: notes from the battlefield.FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection.Protective effect of brown Brazilian propolis against acute vaginal lesions caused by herpes simplex virus type 2 in mice: involvement of antioxidant and anti-inflammatory mechanisms.
P2860
Q27692596-ADF1E2A3-57E1-42AA-BB42-409AFC9C2F11Q33983315-54AEBCA2-C9DB-4839-B098-FA896F0DCD49Q34251265-F8B0DFBA-80A0-4738-8685-995C6A0AC7D1Q35226049-FC7BD827-ADFB-42F1-8273-EED38E3DB9A9Q35871689-F9A63811-F979-43C6-AC00-FB850DC1A45FQ36343355-20E2D2F8-888D-4886-A621-DA14BC4EE31EQ36520832-5C21FE72-A88B-4255-A3F7-74B636DEDC2FQ36555158-403489A0-18E1-4BE5-9001-76ABD200E90CQ36640429-25786B35-B9D4-468A-9D8C-03A8BFC2245EQ36865422-27429D9C-6014-4420-839B-6D89D4666BB1Q36878921-7538B25E-AA2A-4E77-83F2-256FB9754702Q36898823-62116B89-16B6-4223-866F-6314A19A253AQ36933918-B3B0115B-AB7B-4A37-B468-B2251EE5C136Q36978882-0706B3EF-60A2-4338-BDA6-8B6BA0F52BDDQ36981179-86A520BA-2762-45EA-8010-95E13E08F45BQ37212558-E71AB65C-B605-4CE5-B2F8-75B57FF2D7F3Q37288009-9A901041-A75C-4B6B-ACD7-545051081172Q37384857-5FC668F5-4191-4779-92D6-DA948E0C9BD4Q37428262-67EC6DA4-B9CC-42C5-8CA2-91CCB9DB0C80Q45362162-7BF8EF28-268A-4FBB-9F4B-3B2B0CE5FD3C
P2860
Role of mucosal immunity in preventing genital herpes infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Role of mucosal immunity in preventing genital herpes infection.
@ast
Role of mucosal immunity in preventing genital herpes infection.
@en
type
label
Role of mucosal immunity in preventing genital herpes infection.
@ast
Role of mucosal immunity in preventing genital herpes infection.
@en
prefLabel
Role of mucosal immunity in preventing genital herpes infection.
@ast
Role of mucosal immunity in preventing genital herpes infection.
@en
P2093
P356
P1433
P1476
Role of mucosal immunity in preventing genital herpes infection.
@en
P2093
Betsy C Herold
Marla J Keller
Veronica MasCasullo
P304
P356
10.1089/VIM.2005.18.595
P577
2005-01-01T00:00:00Z